David E. Durrant

Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit.

D. Morrison, M. Holderfield, A. Stephen, 2016, Molecular cell.

Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding

D. Morrison, David E. Durrant, Ping Zhang, 2021, bioRxiv.

Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction

P. Alexander, D. Morrison, E. Goncharova, 2021, Molecular Cancer Therapeutics.

Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.

D. Esposito, D. Morrison, Yong Zhou, 2019, Molecular cell.

Swinhopeptolides A and B: Cyclic Depsipeptides from the Sponge Theonella swinhoei That Inhibit Ras/Raf Interaction.

C. Bewley, K. Gustafson, D. Morrison, 2020, Journal of natural products.

Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding

D. Morrison, David E. Durrant, Ping Zhang, 2022, Nature Communications.

Tolypocladamides A-G: Cytotoxic Peptaibols from Tolypocladium inflatum.

D. Morrison, C. J. Henrich, A. Stephen, 2022, Journal of natural products.

Targeting the Raf kinases in human cancer: the Raf dimer dilemma

D. Morrison, David E. Durrant, 2017, British Journal of Cancer.